| Visit | Physionet Directory | Directory | Protocol | Filename | Format | Channels | Sampling rate | Label | description | units | Calibration | Equipment | Device output sampling rate | Experiment | | | | | |
| Day 1 | Not Uploaded | Screening | ICF | | | | | | | | | | | | | | | | |
| | | PCP permission | | | | | | | | | | | | | | | | |
| | | Blood draw | | | | | | | | | | | | | | | | |
| | | Retinal imaging | | | | | | | | | | | | | | | | |
| Day 1 | Not Uploaded | TCD | TCD window | | | | | | | | | | | | | | | | |
| Day 1 | Data/Labview/ Head-upTilt_ Day1 | Head-up tilt test | Deep breathing at 0.1Hz | | | | | | | | | | | | | | | | |
| | | Valsalva maneuver | | | | | | | | | | | | | | | | |
| | | 5-minutes head-up tilt test | S#####DA.dat | | 1 | | marker | | | | | | | | | | | |
| | | | | | 2 | | ECG | ECG | | | | | | | | | | |
| | | | | | 3 | | ABP | finger blood pressure waveform | mmHg | *100 | Finapress | 100 HZ | | | | | | |
| | | | | | 4 | | Mcar | right middle cerebral artery flow velocity waveform | cm/s | | Multi | | empty channels not recorded | | | | | |
| | | | | | 5 | | Mcal | left middle cerebral artery flow velocity waveform | cm/s | | MultiDop X4, DWL Neuroscan Inc, Sterling, VA | 50 Hz | empty channels not recorded | | | | | |
| | | | | | 6 | | Radi | radial artery flow velocity waveform | c,/s | | | | empty channels not recorded | | | | | |
| | | | | | 7 | | Thermst | respiration with nasal thermistor | relative | | thermisor | | | | | | | |
| | | | | | 8 | | Flow rate | respiration flow rate | | | Capnomac Ultima | | | | | | | |
| | | | | | 9 | | O2 | end tidal O2 | mmHg | *9.09 | Capnomac Ultima | | | | | | | |
| | | | | | 10 | | CO2 | end tidal CO2 | mmHg | *7.74 | Capnomac Ultima | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| Day 1 | Not Uploaded | Portapress | Beat-to-beat BP | Portapress resting continuous beat-to-beat BP during head-up tilt (day 1) recording | | | | | | | | | | | | | | | |
| | | | S####D_Portapress.dat | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | Note: This was recorded during Head-up tilt test. Not all the subjects had a recording. | | | | | | | | | | | | | | | |
| | | | Note: During recording the machine did not work proprerly, so files which are labeled as Beat1, Beat2, Beat 3 and Beat4. It means those files are from the same subject. | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| Day 1 | Data/Pedar | Pedar | 12 minute Walking test | Walk test 1&2 ( walk1 around 11 am and walk 2 in the afternoon, normal hallway walking for 12 min recorded with EMG channels using ME6000) and foot pressure distribution using pedar mobile, some subjects also have Portapress beat-to-beat blood pressure) | | | | | | | | ME6000 | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | Walking test- foot pressure distribution and walking characteristics using Pedar Mobile | | | | | | | | | | | | | | | |
| | | | S####DA.ASC_Pedar | DAT | | | | | | | | | | | | | | |
| | | | S####DA.ASC_Pedar | HEA | | | | | | | | | | | | | | |
| | | | | | 16 | | | | | | | | | | | | | |
| | | | | | header: filename, left insole #, right insole #, mean step left, mean step right, min and max step, total time (s econds), distance ( meters),velocity (m/s) | | | | | | | | | | | | | |
| | | | | | 1 | step_no | | | | | | | | | | | | |
| | | | | | 2 | foot | | | | | | | | | | | | |
| | | | | | 3 | max. force[N] | | | | | | | | | | | | |
| | | | | | 4 | mean force[N] | | | | | | | | | | | | |
| | | | | | 5 | max pressure [N/cm²] | | | | | | | | | | | | |
| | | | | | 6 | start | | | | | | | | | | | | |
| | | | | | 7 | start in % of total time | | | | | | | | | | | | |
| | | | | | 8 | stride | | | | | | | | | | | | |
| | | | | | 9 | step | | | | | | | | | | | | |
| | | | | | 10 | stance | | | | | | | | | | | | |
| | | | | | 11 | stance in % of stride | | | | | | | | | | | | |
| | | | | | 12 | swing | | | | | | | | | | | | |
| | | | | | 13 | swing in % | | | | | | | | | | | | |
| | | | | | 14 | init double in % | | | | | | | | | | | | |
| | | | | | 15 | single limb support % | | | | | | | | | | | | |
| | | | | | 16 | terminate double % | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| Day 2 | Data/Labview/ Head-upTilt_ Day2 | Labview | Head up tilt | Vasoreactivity, Valsalva maneuver, Head up tilt | | | | | | | | | | | | | | | |
| | TCD | with TCD | | | | | | | | | | | | | | | | |
| | | Valsalva manuever | | | | | | | | | | | | | | | | |
| | | 5 min supine baseline | S####DB.dat | Labview | 10 | 500 Hz | | | V | | | | | | | | | |
| | | 3 min hyperventilation | | | | | | | | | | | | | | | | |
| | | 3 min CO2 rebreathing | | | 1 | | marker | | | | | | baseline | Valsalva maneuver | hyperventilation | Co2 rebreathing | head-up tilt | baseline |
| | | 5 min supine rest | | | 2 | | ECG | ECG | | | | | | | | | | |
| | | Head up tilt 10 min | | | 3 | | ABP | finger blood pressure waveform | mmHg | *100 | Finapress | 100 HZ | | | | | | |
| | | | | | 4 | | Mcar | right middle cerebral artery flow velocity waveform | cm/s | | Multi | | | | | | | |
| | | | | | 5 | | Mcal | left middle cerebral artery flow velocity waveform | cm/s | | MultiDop X4, DWL Neuroscan Inc, Sterling, VA; | 50 Hz | | | | | | |
| | | | | | 6 | | Radi | radial artery flow velocity waveform | c,/s | | | | | | | | | |
| | | | | | 7 | | Thermst | respiration with nasal thermistor | relative | | thermisor | | | | | | | |
| | | | | | 8 | | Flow rate | respiration flow rate | | | Capnomac Ultima | | | | | | | |
| | | | | | 9 | | O2 | end tidal O2 | mmHg | *9.09 | Capnomac Ultima | | | | | | | |
| | | | | | 10 | | CO2 | end tidal CO2 | mmHg | *7.74 | Capnomac Ultima | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| Day 2 | Data/Labview/Sit-To-Stand | labview-sit-to-stand | Sit-to stand with eyes open and closed | Sit-to-stand Test | | | | | | | | | | | | | | | |
| | | 5 min sitting with eyes open on balance platform with simultaneous cardiovascular, TCD | | | | | | | | | | | | | | | | |
| | | 5 min standing with eyes open on balance platform with simultaneous cardiovascular, TCD and balance measures | | | | | | | | | | | | | | | | |
| | | 5 min sitting with eyes closed on balance platform with simultaneous cardiovascular, TCD | | | | | | | | | | | | | | | | |
| | | 5 min standing with eyes closed on balance platform with simultaneous cardiovascular, TCD and balance measures | | | | | | | | | | | | | | | | |
| | | | S####DC.dat | Labview | 15 | 1000 Hz | | | V | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | 1 | | marker | | | | | | sitting 5min | standing eyes open 3min | sitting | standing eyes closed | | |
| | | | | | 2 | | ECG | ECG | | | | | | | | | | |
| | | | | | 3 | | ABP | finger blood pressure waveform | mmHg | *100 | Finapress | | | | | | | |
| | | | | | 4 | | Mcar | right middle cerebral artery flow velocity waveform | cm/s | | Multi | | | | | | | |
| | | | | | 5 | | Mcal | left middle cerebral artery flow velocity waveform | cm/s | | MultiDop X4, DWL Neuroscan Inc, Sterling, VA; | | | | | | | |
| | | | | | 6 | | Radi | radial artery flow velocity waveform | cm/s | | | | | | | | | |
| | | | | | 7 | | Thermst | respiration with nasal thermistor | relative | | thermisor | | | | | | | |
| | | | | | 8 | | Flow rate | respiration flow rate | ml/s | | Capnomac Ultima | | | | | | | |
| | | | | | 9 | | O2 | end tidal O2 | mmHg | *9.09 | Capnomac Ultima | | | | | | | |
| | | | | | 10 | | CO2 | end tidal CO2 | mmHg | *7.74 | Capnomac Ultima | | | | | | | |
| | | | | | 11 | | fx | sway trajectory in mediolateral direction | mm | | Kistler Force plate, Amherst MA | | | | | | | |
| | | | | | 12 | | fy | sway trajectory in anteroposterior direction | mm | | | | | | | | | |
| | | | | | 13 | | fz | sway trajectory in vertical direction | mm | | | | | | | | | |
| | | | | | 14 | | px | center of pressure x component | mm | | | | | | | | | |
| | | | | | 15 | | py | center of pressure x component | mm | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | S#####DC.ch1-10.dat | Labview | 10 | 1000 Hz | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | 1 | | marker | | | | | | | | | | | |
| | | | | | 2 | | ECG | ECG | | | | | | | | | | |
| | | | | | 3 | | ABP | finger blood pressure waveform | mmHg | *100 | Finapress | | | | | | | |
| | | | | | 4 | | Mcar | right middle cerebral artery flow velocity waveform | cm/s | | Multi | | | | | | | |
| | | | | | 5 | | Mcal | left middle cerebral artery flow velocity waveform | cm/s | | MultiDop X4, DWL Neuroscan Inc, Sterling, VA; | | | | | | | |
| | | | | | 6 | | Radi | radial artery flow velocity waveform | cm/s | | | | | | | | | |
| | | | | | 7 | | Thermst | respiration with nasal thermistor | relative | | thermisor | | | | | | | |
| | | | | | 8 | | Flow rate | respiration flow rate | ml/s | | Capnomac Ultima | | | | | | | |
| | | | | | 9 | | O2 | end tidal O2 | mmHg | *9.09 | Capnomac Ultima | | | | | | | |
| | | | | | 10 | | CO2 | end tidal CO2 | mmHg | *7.74 | Capnomac Ultima | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| Day 3 | Not uploaded | 3T MRI | Anatomical MRI | MRI- anatomical, CBF regional perfusiona dn paerfusion in vascular territories; CO2 vasoreactivity to hyperventilation and C02 rebreathing | | | | | | | | | | | | | | | |
| | | Perfusion MRI | 3Tesla GE Signa Vhi or Excite scanner and phase arrays head coil ( GE Medical Systmes, Milwaukee, WI) | | | | | | | | | | | | | | | |
| | | | MP-RAGE | | | | | MP-RAGE) (repetition | ml or % of total brain volume | | | | | | | | | |
| | | | | | | | | time [TR]/echo time [TE]/inversion time [TI] 7.8/3.1/600 | | | | | | | | | | |
| | | | | | | | | msec, 3.0 mm slice thickness, 52 slices, bandwidth 122 Hz | | | | | | | | | | |
| | | | | | | | | per pixel, flip angle 10°, 24 cm 24 cm field of view [FOV], | | | | | | | | | | |
| | | | | | | | | 256 192 matrix size) | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | FLAIR | | | | | fluid-attenuated inversion recovery | | | | | | | | | | |
| | | | | | | | | (FLAIR) (TR/TE/TI 11,000/161/2,250 msec, 5 mm slice | | | | | | | | | | |
| | | | | | | | | thickness, 30 slices, bandwidth 122 Hz per pixel, flip angle | | | | | | | | | | |
| | | | | | | | | 90°, 24 cm 24 cm FOV, 256 160 matrix size), | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | DWI | | | | | diffusion-weighted image (b value of 1,000 seconds/ | | | | | | | | | | |
| | | | | | | | | mm2, TR/TE 10,000/86.6 msec, 5 mm slice thickness, bandwidth | | | | | | | | | | |
| | | | | | | | | 250 kHz, 128 128 matrix size | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | | | CASL | CBF | | | | three-dimensional stack of | mL · 100 g1 · min1 | | | | | | | | | |
| | | | | | | | | interleaved spirals fast spin echo sequence (TR/TE 6,000/ | | | | | | | | | | |
| | | | | | | | | 23.8 msec, echo train length 66, with a 18 18 cm FOV, in | | | | | | | | | | |
| | | | | | | | | the coronal plane and 64 slices with thickness 3.8 mm, eight | | | | | | | | | | |
| | | | see Zhao et al. Neurology 2009 ;72:643-649 for procecessing details | | | | | spiral interleaves, two averages and a bandwidth62.5 kHz). | | | | | | | | | | |
| | | | Transcranial Doppler | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| Day 4 | Not uploaded | Neurological Examination | The physician assessed for the presence of neuropathy using the neuropathy checklist. | | | | | | | | | | | | | | | | |